Ptychopetalum olacoides, a traditional Amazonian “nerve tonic”, possesses anticholinesterase activity

[1]  E. Elisabetsky,et al.  Anxiogenic properties of Ptychopetalum olacoides Benth. (Marapuama) , 2002, Phytotherapy research : PTR.

[2]  D. S. Nunes,et al.  Antioxidant Action of an Ethanol Extract of Ptychopetalum olacoides , 2002 .

[3]  D. Newman,et al.  Natural Product Drug Discovery in the Next Millennium , 2001, Pharmaceutical biology.

[4]  D. Milatović,et al.  Atypical effect of some spin trapping agents: reversible inhibition of acetylcholinesterase. , 2000, Free radical biology & medicine.

[5]  P. Adlard,et al.  The cause of neuronal degeneration in Alzheimer's disease , 2000, Progress in Neurobiology.

[6]  A. Cross,et al.  A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066 , 1999, Neuropharmacology.

[7]  A. Nordberg,et al.  Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease , 1998, Drug safety.

[8]  X. Tang,et al.  Comparative Studies of Huperzine A, E2020, and Tacrine on Behavior and Cholinesterase Activities , 1998, Pharmacology Biochemistry and Behavior.

[9]  E. Elisabetsky,et al.  Is there a psychopharmacological meaning for traditional tonics , 1998 .

[10]  J. Cummings,et al.  The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. , 1998, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[11]  X. Tang,et al.  Huperzine A, a novel promising acetylcholinesterase inhibitor , 1996, Neuroreport.

[12]  L. Friedhoff,et al.  The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial , 1996 .

[13]  C. H. Park,et al.  Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa. , 1996, Planta medica.

[14]  M. Sofroniew,et al.  Reduced retrograde labelling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats , 1996, Neuroscience.

[15]  H. Soreq,et al.  Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice , 1995, Current Biology.

[16]  A. Parent,et al.  Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  P. Watkins,et al.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. , 1994, JAMA.

[18]  S. Yoshida,et al.  Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. , 1993, European journal of pharmacology.

[19]  W. Griffith,et al.  Age-related decline in cholinergic synaptic transmission in hippocampus , 1993, Neurobiology of Aging.

[20]  H. Sugimoto,et al.  Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives. , 1992, Journal of medicinal chemistry.

[21]  James A. Duke,et al.  Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants , 1992 .

[22]  A. Kozikowski,et al.  Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase. , 1991, European journal of pharmacology.

[23]  G. Bisso,et al.  Size and charge isomers of acetylcholinesterase in the cerebral cortex of young and aged rats , 1991, Neurochemical Research.

[24]  R. Floyd,et al.  Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. B. Cohen,et al.  General occurrence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrate. , 1991, Biochimica et biophysica acta.

[26]  P. Abelson.  Medicine from plants. , 1990, Science.

[27]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[29]  D. S. Nunes,et al.  Psychopharmacological Properties of Ptychopetalum Olacoides bentham (Olacaceae) , 1998 .

[30]  H. Soreq,et al.  Cholinergic drug resistance and impaired spatial learning in transgenic mice overexpressing human brain acetylcholinesterase. , 1996, Progress in brain research.

[31]  C. Moretti,et al.  Pharmacopées traditionnelles en Guyane : créoles, palikur, wayãpi , 1987 .

[32]  H. Auterhoff,et al.  Der lipophile Inhaltsstoff von Muira puama 3. Mitt , 1971 .

[33]  E. Steinmetz.  Muira Puama (“Potency wood”) , 1962 .